New federal review finds some long-standing concerns may have been overstated
Millions of American men suffering from low testosterone may soon find it easier to receive treatment after federal health officials announced plans to update warning labels on testosterone replacement therapies.
The U.S. Department of Health and Human Services (HHS) is asking manufacturers to revise product labels to reflect newer research showing that some of the risks long associated with testosterone therapy appear to be lower than once believed. The changes have not yet been finalized, but they signal a significant shift in how the federal government views the treatment.
For many families, the announcement is about more than men’s health.
Low testosterone has become an increasingly common diagnosis among middle-aged and older men. Symptoms can include fatigue, low sex drive, difficulty maintaining muscle mass, mood changes and reduced energy. Because those symptoms often affect relationships, many women are also paying attention as more men ask their doctors whether testosterone therapy could help.
One of the biggest proposed changes would remove language suggesting that testosterone therapy has not been proven safe or effective for men whose testosterone declines with age. HHS says newer research provides stronger evidence that many men with documented low testosterone can benefit from treatment when properly diagnosed and monitored.
The agency is also asking manufacturers to update warnings related to heart disease, prostate cancer and enlarged prostate—three issues that have shaped medical decisions for years.
Perhaps the biggest surprise involves heart health.
For more than a decade, concerns that testosterone therapy might increase the risk of heart attacks or strokes caused many doctors to prescribe it cautiously. But HHS says newer studies, including a large clinical trial involving more than 5,200 men, found no meaningful increase in major cardiovascular events among men receiving testosterone therapy.
The government is also revising its position on prostate cancer.
Current warning labels broadly caution against testosterone therapy in men with known or suspected prostate cancer. Under the proposed changes, that warning would be narrowed to men whose prostate cancer has spread beyond the prostate after newer research found no overall increase in prostate cancer among men receiving testosterone replacement therapy.
Another proposed revision would soften warnings that testosterone therapy worsens symptoms of an enlarged prostate. Federal reviewers found little evidence that men with mild or moderate enlargement experienced worsening symptoms, although doctors would still closely monitor men with more severe prostate problems.
Medical experts caution that the proposed changes should not be interpreted as a recommendation that every aging man should begin testosterone therapy.
Doctors emphasize that testosterone is still a prescription medication intended for men who have both persistent symptoms and laboratory tests confirming low hormone levels. Most specialists recommend confirming low testosterone with at least two morning blood tests before treatment begins.
Experts also note that testosterone therapy is not without risks. Possible side effects include acne, skin irritation, increased red blood cell counts, blood clots, irregular heart rhythms, breast enlargement and reduced sperm production. Men receiving treatment typically require regular blood work and follow-up visits to monitor their health.
Researchers say the therapy offers the greatest benefit for men who truly have low testosterone rather than those seeking more energy or muscle simply because they are getting older.
While HHS has requested the label revisions, the changes must still be reviewed before appearing on testosterone products. Even so, many specialists view the announcement as recognition that years of additional research have changed the scientific understanding of testosterone therapy.
For men experiencing symptoms—or for spouses concerned about changes in their partner’s health—the message remains the same: don’t rely on internet advice or social media. Talk with a healthcare provider, get properly tested, and weigh both the potential benefits and risks before deciding whether testosterone therapy is appropriate.